ArticleOxidative medicine and cellular longevity2020

Drp-1 as Potential Therapeutic Target for Lipopolysaccharide-Induced Vascular Hyperpermeability.

Xu Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.